A lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib

• Main Authors: Yan Chen (Author), Bo Jiang (Author), Yuange He (Author), Chu Zhang (Author), Wenjie Zhou (Author), Cheng Fang (Author), Dejian Gu (Author), Minxia Zhang (Author), Mei Ji (Author), Juntao Shi (Author), Xin Yang (Author)
• Format: Book
• Published: BMC, 2022-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Targeted therapy has revolutionized the treatment of patients with malignancies harboring mutations in driver genes and has brought a favorable survival benefit to the population with actionable oncogenic mutations. In recent years, the MET exon14 skipping mutation has been recog...